# FDA 483 - Magna Pharmaceuticals Inc - October 29, 2021

Source: https://www.globalkeysolutions.net/records/483/magna-pharmaceuticals-inc/cd0c0bfe-031e-466e-9898-313ff3fc385e

> FDA 483 for Magna Pharmaceuticals Inc on October 29, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Magna Pharmaceuticals Inc
- Inspection Date: 2021-10-29
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Magna Pharmaceuticals Inc. in Louisville, KY, revealed a significant deficiency in their quality system. The firm failed to adequately establish procedures for corrective and preventive actions (CAPA). This indicates a fundamental gap in their ability to address and prevent recurring issues.

## Related Officers

- [Shannon A. Gregory](https://www.globalkeysolutions.net/people/shannon-a-gregory/3e791321-dced-4e1d-89a1-3da91d577961)

Company: https://www.globalkeysolutions.net/companies/magna-pharmaceuticals-inc/80329531-934f-4127-bba0-03517e50c916

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22